Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Institutul National de Endocrinologie C.I. Parhon

Research site

Romania Bulevardul Aviatorilor 34-36, Bucharest, Romania

  • Hyperadrenocorticism · Pituitary-dependent Cushing's syndrome
  • Adult patients

About Specializations

Institutul National de Endocrinologie C.I. Parhon in Bucharest, Romania specialises in clinical trials of conditions such as Hyperadrenocorticism, Pituitary-dependent Cushing's syndrome, and other specialisations. This site conducts important research.

Main research areas of the site

Endocrinology and Metabolic Disorders

The medical center is at the forefront of research in Endocrinology, focusing on disorders such as Cushing's Disease and Hypercortisolism. These conditions are characterized by excessive production of the hormone cortisol, leading to significant health challenges.

  • Cushing's Disease
  • Hypercortisolism related to benign adrenal tumors

Through innovative trials, the center is exploring new therapeutic agents like Lu AG13909 and SPI-62, aiming to regulate cortisol levels and improve patient outcomes. The research not only evaluates the efficacy of these treatments but also their safety and pharmacokinetic profiles, contributing to a deeper understanding of these complex conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Bulevardul Aviatorilor 34-36BucharestRomania
Open in maps ↗
Recruiting now
no trials
Conditions studied
2

More sites in BucharestRomania

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Hyperadrenocorticism

Not recruiting

Study of SPI-62 for Treating Cushing's Syndrome in Patients with Benign Adrenal Tumors

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:4-{5-[2-(4-Chloro-2,6-Difluorophenoxy)Propan-2-Yl]-4-Methyl-4H-1,2,4-Triazol-3-Yl}-3-Fluorobenzamide
  • Sponsor:Sparrow Pharmaceuticals Inc.

Pituitary-dependent Cushing's syndrome

Not recruiting

Study of Lu AG13909 in Adults with Cushing's Disease to Evaluate Safety and Effectiveness

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:AG13909
  • Sponsor:H. Lundbeck A/S
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.